Clesrovimab, CAS 2429913-18-6

Product Description: Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Qiu X, et al. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth Factor Rev. 2022 Dec;68:37-53./[2]Odumade OA, et al. Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection. Clin Infect Dis. 2022 Aug 15;75(Supplement_1):S130-S135.

CAS Number: 2429913-18-6

Molecular Weight: N/A

Compound Purity: 99.62

Research Area: Infection

Solubility: 10 mM in DMSO

Target: RSV

• SKU: MEXHY-P99804-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99804-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated